Daewoong initiates clinical trial assessing microneedle patch loaded with GLP-1 owenhaskins Nov 8, 2023 2 min read Daewoong Pharmaceutical will commence full-scale development of an obesity treatment utilising a microneedle patch loaded with glucagon-like peptide-1 (GLP-1) analogues
However, this possibility remains to be investigated
It turns out, your body has a "biological boardroom" where hormones negotiate exactly how hungry you feel, how much energy you burn, and how your blood sugar behaves
To further note, in the field of weight-loss treatment, significant work is underway in parallel, on GIP agonist, amylin agonist, glucagon agonist, PYY agonist, either separately or in combination especially with GLP-1 agonist